ScholarLens Back to search
2008•PLoS MedicineOpen access

Informed Consent and Shared Decision-Making: A Requirement to Disclose to Patients Off-Label Prescriptions

Michael S. Wilkes, Margaret Z. Johns

Open full text 54 citations

Abstract

Michael Wilkes and Margaret Johns argue that the doctrine of informed consent should require doctors to disclose to patients when they are prescribing a drug off-label.

Open-access reader

About this research paper

What this paper is about

Michael Wilkes and Margaret Johns argue that the doctrine of informed consent should require doctors to disclose to patients when they are prescribing a drug off-label.

Why it matters

OpenAlex reports 54 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Michael Wilkes and Margaret Johns argue that the doctrine of informed consent should require doctors to disclose to patients when they are prescribing a drug off-label.

Key concepts: Medicine, Off-label use, Gabapentin, Informed consent, Medical prescription, Headaches, Drug, Alternative medicine

Related papers

Related paper 1Related paper 2Related paper 3
Back to paper searchBrowse research topicsOriginal source
Informed Consent and Shared Decision-Making: A Requirement to Disclose to Patients Off-Label Prescriptions — Research Paper | ScholarLens